Stronger and higher dose opioids linked to greater all-cause mortality risk
A new international study spanning the United Kingdom, United States, and Canada has revealed important insights into the risks associated...
A new international study spanning the United Kingdom, United States, and Canada has revealed important insights into the risks associated...
Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the...
Brain tumour experts at Salford Royal have treated the first patient in the UK with a new investigational drug that...
Mark Warburton is a Clinical Trials Administrator working with the Metabolic Medicine Research Team at Salford Care Organisation. Over the...
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company pioneering graphene-based neural technologies, announced today the world’s first human procedure of...
Another six Northern Care Alliance NHS Foundation Trust outstanding clinicians and researchers have been awarded MAHSC Honorary Clinical Chairs in...
Patients from all over the UK travel to Salford Royal’s fibromuscular dysplasia clinic, the first of its kind in the...
Salford was the highest recruiting site in the UK (with 56 participants) to the Hemoglobin Transfusion Threshold in Traumatic Brain...
Stroke neurologist Adrian Parry-Jones has been appointed Professor of Vascular Neurology by The University of Manchester in recognition of the...
Identifying patients at high-risk for end-stage renal disease (ESRD) is crucial for providing the best possible care and targeted prevention...